Demographics and baseline characteristics
Total patients enrolled (N = 25) | ||
---|---|---|
Variable | Patients, n | % |
Age, y | ||
Median | 65 | |
Range | 46–80 | |
Sex | ||
Male | 15 | 60 |
Female | 10 | 40 |
ECOG performance status | ||
0 | 16 | 64 |
1 | 9 | 36 |
Race | ||
Caucasian | 24 | 96 |
African American | 1 | 4 |
Histology | ||
Adenocarcinoma | 24 | 96 |
Acinar | 1 | 4 |
Location of biopsy | ||
Liver metastasis | 17 | 68 |
Primary pancreatic mass | 4 | 16 |
Omental metastasis | 2 | 8 |
Other (perihepatic mass, neck lymph node) | 2 | 8 |
Serum CA 19-9 | ||
Median, U/mL | 3211 | |
Range, U/mL | 4–429,939 | |
>150 U/mL | 18 | 72 |
Biopsy | ||
Baseline | 25 | 100 |
At 3 wks | 23 | 92 |